Table 2.
Concentrations of sVCAM-1, sICAM-1, sTM, and sE-selectin in the patients with well-controlled type 2 diabetes and uncontrolled diabetes, compared with the controls
Group | sICAM-1 (ng/ml) | sVCAM-1 (ng/ml) | sE-selectin (ng/ml) | sTM (ng/ml) |
I (n=35) | 372.10 | 709.45 | 30.90 | 2.40 |
275.10/503.70 | 540.60/1081.10 | 21.20/38.80 | 1.84/2.88 | |
II (n=27) | 288.60 | 1152.20 | 57.42 | 3.36 |
223.90/341.80 | 753.40/1569.90 | 42.80/76.60 | 2.80/3.90 | |
III (n=25) | 201.82 | 221.70 | 21.10 | 2.50 |
161.46/244.79 | 110.30/753.40 | 9.90/24.59 | 1.78/4.60 | |
| ||||
P-value | ||||
I vs. II | 0.0118 | 0.0375 | 0.00001 | 0.0004 |
I vs. III | 0.000002 | 0.0281 | 0.0029 | 0.1925 |
II vs. III | 0.0021 | 0.0001 | 0.000001 | 0.3374 |
The values of the parameters are shown as median (Me) and lower (Q1)/upper (Q3) quartile